Illustration showing the molecular structure of repaglinide, a drug used to treat type 2 diabetes. It belongs to a class of drug known as meglitinides which bind to ATP-dependent potassium channels in pancreatic beta cells, stimulating insulin release. It belongs to a class of drug known as meglitinides which bind to ATP-dependent potassium channels in pancreatic beta cells, stimulating insulin release. Insulin, in turn, increases cellular glucose uptake, reducing blood sugar levels, making repaglinide a suitable treatment for type 2 diabetes. Atoms are represented as spheres and are colour-coded: carbon (grey), hydrogen (white), nitrogen (blue) and oxygen (red).

px px dpi = cm x cm = MB
Details

Creative#:

TOP29693956

Source:

達志影像

Authorization Type:

RM

Release Information:

須由TPG 完整授權

Model Release:

N/A

Property Release:

N/A

Right to Privacy:

No

Same folder images:

Same folder images